This most up-to-date twist from the Lykos Therapeutics saga threatens a major overhaul of the business’s method and path, with Musk ally and billionaire Trader Antonio Gracias showing to desire to choose the corporate again towards its nonprofit drug improvement roots and a far more Doblinite philosophy.“I expended the weekend conversing a grea